Main Street Research’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,318
Closed -$206K 152
2021
Q2
$206K Hold
1,318
0.02% 136
2021
Q1
$205K Buy
+1,318
New +$204K 0.02% 125
2018
Q2
Sell
-2,032
Closed -$215K 127
2018
Q1
$215K Buy
2,032
+206
+11% +$23.9K 0.03% 105
2017
Q4
$214K Hold
1,826
0.03% 104
2017
Q3
$208K Hold
1,826
0.03% 107
2017
Q2
$228K Hold
1,826
0.04% 114
2017
Q1
$217K Buy
+1,826
New +$207K 0.04% 108
2016
Q4
Sell
-1,826
Closed -$231K 121
2016
Q3
$231K Hold
1,826
0.05% 100
2016
Q2
$213K Buy
+1,826
New +$207K 0.04% 103
2015
Q3
Sell
-2,299
Closed -$244K 139
2015
Q2
$244K Buy
2,299
+309
+16% +$34.2K 0.05% 128
2015
Q1
$227K Hold
1,990
0.05% 125
2014
Q4
$219K Buy
+1,990
New +$210K 0.05% 127
2014
Q1
Sell
-3,042
Closed -$275K 147
2013
Q4
$275K Hold
3,042
0.07% 125
2013
Q3
$243K Sell
3,042
-279
-8% -$22K 0.07% 122
2013
Q2
$242K Buy
+3,321
New +$248K 0.07% 123

Other funds holding ZBH

Main Street Research's ZBH Position: Q3 2021 in Review

Main Street Research sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 1,318 shares — an estimated $206K sold.

Main Street Research first reported a position in ZBH in Q2 2013 and held it in 15 quarters. The position peaked at $275K in Q4 2013. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

  • Main Street Research reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
  • Main Street Research sold 1,318 Zimmer Biomet shares in Q3 2021, an estimated $206K.
  • Main Street Research first reported a position in Zimmer Biomet in Q2 2013 and held it in 15 quarters.
  • Main Street Research's Zimmer Biomet position peaked at $275K in Q4 2013.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Main Street Research's 13F filing for Q3 2021, filed 12 Nov 2021.